- Combined company will generate well over $100 million of ARR and signals a 
significant transformation in the future of software and data management in 
research labs.

- Enabling over one million scientists to improve research and lab efficiency.

- Facilitating rapid data access and exchange between scientists around the 
world, ultimately giving customers a competitive edge.

Insightful Science ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=1583532326&u=https%3A%2F%2Fwww.insightfulscience.com%2F&a=Insightful+Science 
), a leading software provider serving the global life sciences community, 
announced today that it has entered into a transaction to acquire Dotmatics ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=3688807434&u=https%3A%2F%2Fwww.dotmatics.com%2F&a=Dotmatics 
), an industry leading cloud-based scientific R&D data management platform. 

By integrating Insightful Science's software applications into Dotmatics 
cloud-first enterprise data management solution, the company will provide an 
end-to-end scientific research platform. This combination further improves 
laboratory efficiency and accelerates the pace of scientific innovation by 
facilitating more rapid data access, analysis and exchange between scientists 
around the world. 

Insightful Science is a software company with purpose-built data analysis and 
bioinformatics applications for life sciences. The company portfolio serves a 
diverse set of one million scientists in academic, corporate, and government 
institutions around the world. Examples of products within the Insightful 
Science portfolio ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=833327040&u=https%3A%2F%2Fwww.insightfulscience.com%2Fproducts.html&a=Insightful+Science+portfolio 
) include GraphPad Prism ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=498378251&u=https%3A%2F%2Fwww.graphpad.com%2F&a=GraphPad+Prism 
), Geneious ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=826394614&u=https%3A%2F%2Fwww.geneious.com%2F&a=Geneious 
) DNA data analysis solutions, SnapGene ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=715213681&u=https%3A%2F%2Fwww.snapgene.com%2F&a=SnapGene 
), and other leading R&D solutions.

Dotmatics is an enterprise scientific informatics SaaS provider that is driving 
the digitalization of laboratory data workflows for scientific discovery and 
innovation across the life sciences, chemicals and materials industries. 

"This announcement signals a significant transformation in the future of 
software and data management in research labs," said Thomas Swalla, CEO of 
Insightful Science. "Together our complementary businesses create an end-to-end 
cloud-first scientific research platform that stands apart in our collective 
ability to support data-driven research. We are beyond enthusiastic about the 
impact we can have on increasing the speed of scientific innovation, and 
ultimately helping to make the world a healthier, cleaner, and better place to 
live."

"The number one challenge for pharmaceutical, biotech and chemical innovation 
companies today is how to manage the enormous volume — and promise — of data 
generated in labs," said Dr Steve Gallagher, Co-founder and CEO of Dotmatics. 
"This combination allows us to expand investments in our Dotmatics platform and 
strengthen our brand as a leading enterprise informatics solution provider. We 
will bring Insightful Science's leading biologics applications to our 
customers, further accelerating their discovery processes. In addition, we have 
the opportunity to bring the Dotmatics cloud and collaboration capabilities to 
the diverse community of over one million scientists already using Insightful 
Science tools."

Digital Transformation to Chart the Course for the Lab of the Future

Scientific research and innovation R&D is in the midst of a pivotal 
transformation. Scientific knowledge and growth in pharmaceutical drug 
discovery and chemicals and materials innovation is increasing at a faster pace 
than ever before. The research process has been transformed from transactional 
and process driven, to data driven. As a result, scientists require 
increasingly powerful and integrated informatics tools to analyze ever-more 
diverse sets of data; and laboratories and companies need better workflow and 
data management solutions to help scientists harness the power of these 
insights. Companies that own the cleanest, best annotated data to power their 
AI analytics and decision making, will be the best placed to be successful in 
this new paradigm. 

Transaction Details

Insightful Science is a privately held portfolio company of Insight Partners ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=2060882214&u=https%3A%2F%2Fwww.insightpartners.com%2F&a=Insight+Partners 
), the leading global venture capital and private equity firm investing in 
high-growth technology and software ScaleUp companies. 

"The combination of these two entities brings an exciting new solution to 
market," said Jeff Lieberman, Managing Director at Insight Partners. "This 
announcement and collaboration is a significant opportunity for the life 
sciences, chemicals and materials industries. We are incredibly optimistic 
about the future of the company and its clear path to doing for life sciences 
and chemical innovation what other market-leading platforms have done in 
engineering, design, and later-stage drug development."

Alastair Hill, Co-founder and CIO of Dotmatics added, "Since initial growth 
equity investment by Scottish Equity Partners (SEP), we have been supported to 
make incredible progress in scaling our business and driving product 
innovation. We would like to thank them for their support as we enter the next 
exciting stage in Dotmatics' development, and Jefferies for advising on the 
transaction."

Evercore served as financial advisor and Willkie Farr & Gallagher LLP served as 
legal advisor to Insightful Science on the transaction. Jefferies International 
Ltd served as advisor to Dotmatics.

Scottish Equity Partners ( 
https://c212.net/c/link/?t=0&l=en&o=3103745-1&h=1886644457&u=http%3A%2F%2Fwww.sep.co.uk%2F&a=Scottish+Equity+Partners 
) (SEP) is a leading European growth equity firm, investing in enterprise and 
consumer-focused software and technology companies. 

Keith Davidson, Partner at SEP said, "We are pleased to have helped Dotmatics 
grow into a leading cloud-first scientific R&D data platform. We are excited by 
the opportunity that lies ahead for the team and wish them every success in the 
future."  

Subject to the attainment of regulatory clearances, the transaction is expected 
to close in Q2 of 2021. Until closing, the companies will continue to operate 
independently.

For more information, visit www.dotmatics.com and www.insightfulscience.com. 

About Insightful Science
Insightful Science is a life sciences software company that digitally connects 
researchers to their ideas and data, advancing the discovery process. From 
developing new personalized and preventive patient treatment solutions to 
reversing climate change — more than two million researchers at leading life 
science and biopharma enterprises trust Insightful Science products to make the 
world a healthier, cleaner, and better place to live. Products within the 
Insightful Science portfolio were built by prominent scientists, and include 
GraphPad Prism, Geneious Prime and Geneious Biologics, SnapGene, nQuery, 
Cytapex, and more. 

Visit www.insightfulscience.com for more information about the company and its 
products.

About Dotmatics Ltd. www.dotmatics.com 
Dotmatics is a scientific informatics software and services company that is 
driving the automation of laboratory workflows for discovery and innovation 
research - accelerating the journey towards full digitalization and the Lab of 
the Future. 

With a mission to give scientists access to all of their data, all of the time, 
Dotmatics provides a portfolio of tools for fully automated, end-to-end 
workflows including data acquisition, knowledge management, data storage, and 
enterprise querying and reporting. Through these comprehensive solutions, the 
Company is helping its customers to increase lab efficiency and make better 
informed decisions driven by all data.

Dotmatics' customers include many of the world's leading pharmaceutical, 
biotechnology, contract research, chemicals and materials companies. Insight 
into the challenges faced by these organizations enables Dotmatics to focus on 
delivering versatile and intuitive products and services that have potential to 
turn around the productivity deficit in research and accelerate development of 
novel drug candidates or products.

Dotmatics was founded in 2005 by two scientists from Merck Pharmaceuticals 
(MSD). Since then it has built a strong and profitable business with an expert 
team of over 300 scientists, software developers and engineers, and project 
managers. The Company is headquartered in the UK with offices in USA, Korea and 
Japan. 

SOURCE:  Insightful Science

CONTACT: Sarah Jeffery, Zyme Communications, E: 
sarah.jeffery@zymecommunications.com, T: +44 (0)7771 730 919